Gelesis Holdings Inc (GLSHQ)
0.00
USD |
OTCM |
May 10, 16:00
Gelesis Holdings Debt to Equity Ratio: -1.923 for June 30, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2023 | -1.923 |
| March 31, 2023 | -2.227 |
| December 31, 2022 | -2.422 |
| September 30, 2022 | -15.80 |
| Date | Value |
|---|---|
| June 30, 2022 | 6.510 |
| March 31, 2022 | 3.583 |
| December 31, 2021 | -0.1947 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-15.80
Minimum
Sep 2022
6.510
Maximum
Jun 2022
-1.783
Average
-1.923
Median
Jun 2023
Debt to Equity Ratio Benchmarks
| Athersys Inc | -- |
| Infinity Pharmaceuticals Inc | 0.00 |
| Merck & Co Inc | 0.8478 |
| MEI Pharma Inc | -- |
| Bristol-Myers Squibb Co | 3.376 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 95.88M |
| Total Liabilities (Quarterly) | 114.50M |
| Shareholders Equity (Quarterly) | -31.53M |
| Current Ratio | 0.4912 |
| Net Debt Paydown Yield | -186.9% |